Curran Simpson
CIK 1346164 · Chief Executive Officer · last filed 2026-07-06
Curran Simpson is a Chief Executive Officer who has filed 66 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing, for RGNX, was dated Jul 6, 2026. Across all open-market trades the lifetime net is −$25.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.87M
2
66
-$25.77M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGNX | Chief Executive Officer | 343,418 | $11.28 | $3.87M | -$17.42M | 39 | 2026-07-06 |
| HUMAN GENOME SCIENCES INC (HGSI) Delisted | Sr. VP, Operations | 0 | — | — | -$8.35M | 24 | 2012-08-01 |
Recent Filings
66 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-06 | RGNX | Mixed | −4,414 | -$67.8K | EDGAR |
| 2026-01-08 | RGNX | Grant (A) | +144,864 | $0 | EDGAR |
| 2026-01-06 | RGNX | Tax (F) | −18,559 | -$267.2K | EDGAR |
| 2025-10-10 | RGNX | Sell (S) | −20,811 | -$262.6K | EDGAR |
| 2025-10-09 | RGNX | Notice (144) | −20,811 | -$254.3K | EDGAR |
| 2025-10-01 | RGNX | Sell (S) | −7,624 | -$76.5K | EDGAR |
| 2025-09-12 | RGNX | Sell (S) | −7,734 | -$77.5K | EDGAR |
| 2025-09-10 | RGNX | Notice (144) | −15,358 | -$151.9K | EDGAR |
| 2025-07-03 | RGNX | Tax (F) | −4,701 | -$38.7K | EDGAR |
| 2025-01-14 | RGNX | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.